STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13D/A] PRECIGEN, INC. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A
Rhea-AI Filing Summary

Randal J. Kirk and related entities updated their Schedule 13D/A for Precigen, Inc. (PGEN). The filing discloses that on September 17, 2025 the R.J. Kirk Declaration of Trust converted 25,000 shares of 8.00% Series A Convertible Perpetual Preferred Stock into 17,385,257 shares of Common Stock. Between September 18–19, 2025, Kapital Joe, LLC (under common control) sold 5,000,252 shares in open-market transactions for approximately $18,648,905.62. The cover-page holdings show Mr. Kirk with beneficial ownership of 146,295,359 shares (39.4%), RJ DOT 98,831,434 shares (26.6%), Sunset 2020 LLC 16,406,828 shares (4.4%), and Third Security, LLC 27,454,284 shares (7.4%). The filing also notes exercisable warrants (16,666,667) and options (906,512) included in Mr. Kirk's beneficial ownership calculation and incorporates prior amendments.

Positive
  • Conversion transparency: The filing clearly discloses conversion of Preferred Stock into 17,385,257 shares by RJ DOT.
  • Full disclosure of sales: Kapital Joe's open-market sales of 5,000,252 shares for ~$18.65M are explicitly reported.
  • Comprehensive ownership detail: Reporting pages disclose aggregate beneficial ownership and include exercisable warrants and options in calculations.
Negative
  • Share dilution: The conversion and the filing note an increase in shares outstanding used for percentage calculations (company reported conversion of 54,937,411 shares overall), which dilutes existing holders.
  • Affiliate sell-down: Kapital Joe's sale of 5.0M shares represents near-term monetization by a Kirk-controlled entity, reducing that affiliate's stake.

Insights

TL;DR: Kirk significantly increased reported common shares via conversion while a related entity sold 5.0M shares, modestly monetizing holdings.

The conversion of Preferred Stock into 17.4 million common shares materially increases Kirk-affiliated common shares outstanding and is disclosed as an investment action by RJ DOT. The near-term sale of 5.0 million shares by Kapital Joe generated about $18.65 million of proceeds, reducing that affiliate's stake. Beneficial ownership percentages reported reflect inclusion of convertible securities and exercisable warrants/options, which could further affect dilution if exercised. The filing is a standard 13D/A amendment providing transparency on ownership and recent transactions.

TL;DR: The amendment transparently updates conversions and market sales but signals active disposition and potential future dilution from exercisable securities.

The Schedule 13D/A documents a conversion event and subsequent open-market sales by an affiliate under common control. Inclusion of 16,666,667 exercisable warrants and 906,512 options in the ownership calculation is notable for governance because exercise or conversion would change voting power and economic interest. The joint filing agreement and repeated amendments reflect ongoing reporting compliance by the Reporting Persons.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
The indicated amount of Common Stock beneficially owned by Mr. Kirk assumes the full conversion of (i) 25,000 shares of Preferred Stock, as that term is defined herein (ii) 906,512 Options to Purchase Common Stock, which are fully vested and exercisable at the discretion of Mr. Kirk, and (iii) 16,666,667 Warrants to Purchase Common Stock, which are fully vested and exercisable at the discretion of Mr. Kirk.


SCHEDULE 13D




Comment for Type of Reporting Person:
OO - trust; The indicated amount of Common Stock beneficially owned by RJ DOT assumes the full conversion of (i) 25,000 shares of Preferred Stock, as that term is defined herein and (ii) 16,666,667 Warrants to Purchase Common Stock, which are fully vested and exercisable at the discretion of Mr. Kirk.


SCHEDULE 13D




Comment for Type of Reporting Person:
OO - limited liability company


SCHEDULE 13D




Comment for Type of Reporting Person:
OO - limited liability company


SCHEDULE 13D


RANDAL J. KIRK
Signature:/s/ Randal J. Kirk
Name/Title:Randal J. Kirk
Date:09/19/2025
R.J. KIRK DECLARATION OF TRUST
Signature:/s/ Randal J. Kirk
Name/Title:Randal J. Kirk Trustee
Date:09/19/2025
SUNSET 2020 LLC
Signature:/s/ Randal J. Kirk
Name/Title:Randal J. Kirk Manager
Date:09/19/2025
THIRD SECURITY, LLC
Signature:/s/ Randal J. Kirk
Name/Title:Randal J. Kirk Managing Member
Date:09/19/2025

FAQ

What did Randal J. Kirk disclose in the PGEN Schedule 13D/A?

The filing discloses that RJ DOT converted 25,000 shares of Preferred Stock into 17,385,257 shares of Common Stock and that Kapital Joe sold 5,000,252 shares in the open market for approximately $18,648,905.62.

How much of Precigen (PGEN) does Mr. Kirk beneficially own after the amendment?

The cover page reports Mr. Kirk's beneficial ownership as 146,295,359 shares, representing 39.4% of the class based on the filing's calculation.

Are there additional convertible or exercisable securities disclosed for PGEN?

Yes. The filing includes 16,666,667 warrants and 906,512 options exercisable within 60 days that are included in Mr. Kirk's beneficial ownership calculation.

When were the conversion and the sales reported?

The conversion to RJ DOT occurred on September 17, 2025. Kapital Joe's open-market sales occurred between September 18 and September 19, 2025.

How were the proceeds from the Kapital Joe sales reported?

Kapital Joe sold 5,000,252 shares for aggregate net proceeds of approximately $18,648,905.62.
Precigen Inc

NASDAQ:PGEN

PGEN Rankings

PGEN Latest News

PGEN Latest SEC Filings

PGEN Stock Data

1.38B
305.38M
10.47%
66.81%
12.13%
Biotechnology
Pharmaceutical Preparations
Link
United States
GERMANTOWN